The investigation of the provided sample detected an interfering factor against the streptavidin component of the assay causing the falsely elevated value of the ft3iii assay.The investigation did not identify a product problem.The root cause was due to the detected interfering factor against the streptavidin component of the assay.In rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin, or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination, and other findings.
|